| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |